BioCentury
ARTICLE | Financial News

Viralytics raises A$29.6M in equity placement

January 12, 2018 4:35 PM UTC

Immuno-oncology company Viralytics Ltd. (ASX:VLA) raised A$29.6 million ($23.16 million) through the sale of 36.1 million shares at A$0.82 ($0.64) in a placement on Jan. 5 from Lepu Medical Technolog...

BCIQ Company Profiles

Viralytics Ltd.